组织多肽抗原在泌尿系统肿瘤中的预后价值。
Prognostic value of tissue polypeptide antigen in urological neoplasia.
作者信息
Costello C B, Kumar S
出版信息
J R Soc Med. 1985 Mar;78(3):207-10. doi: 10.1177/014107688507800307.
Abstract
The prognostic importance of tissue polypeptide antigen (TPA) in urine samples of patients with urological cancers has been evaluated. TPA concentration correlated well both with the stage of the disease and survival. A simple score system was devised. There was very significant worsening of the prognosis with increasing score.
摘要
组织多肽抗原（TPA）在泌尿系统癌症患者尿液样本中的预后重要性已得到评估。TPA浓度与疾病分期和生存率均密切相关。设计了一个简单的评分系统。随着评分增加，预后显著恶化。
相似文献
1
Prognostic value of tissue polypeptide antigen in urological neoplasia.组织多肽抗原在泌尿系统肿瘤中的预后价值。
J R Soc Med. 1985 Mar;78(3):207-10. doi: 10.1177/014107688507800307.
2
[Urinary tissue polypeptide antigen (TPA) in bladder cancer].[膀胱癌中的尿组织多肽抗原（TPA）]
Nihon Hinyokika Gakkai Zasshi. 1984 Jun;75(6):959-66. doi: 10.5980/jpnjurol1928.75.6_959.
3
The clinical significance of tissue polypeptide antigen (TPA) in the urine of bladder cancer patients.
Br J Urol. 1981 Dec;53(6):578-81. doi: 10.1111/j.1464-410x.1981.tb03264.x.
4
Tissue polypeptide antigen in the follow-up of patients with urinary bladder cancer compared with conventional urine cytology.与传统尿液细胞学检查相比，组织多肽抗原在膀胱癌患者随访中的应用
Hell J Nucl Med. 2010 Sep-Dec;13(3):213-7.
5
Tissue concentrations of tissue polypeptide antigen (TPA) and prostatic specific antigen (PSA) in 42 patients with prostatic carcinoma.42例前列腺癌患者的组织多肽抗原（TPA）和前列腺特异性抗原（PSA）的组织浓度。
Prostate. 2000 Dec 1;45(4):299-303. doi: 10.1002/1097-0045(20001201)45:4<299::aid-pros3>3.0.co;2-i.
6
[Serum and urinary tissue polypeptide antigen (TPA) in patients with urological cancer].[泌尿系统癌症患者的血清和尿液组织多肽抗原（TPA）]
Hinyokika Kiyo. 1985 Dec;31(12):2113-9.
7
Tissue polypeptide antigen in normal and neoplastic urinary bladder. Preliminary reports.
Oncology. 1987;44(2):118-23. doi: 10.1159/000226458.
8
Tissue polypeptide antigen (TPA) as a prognostic aid in human prostatic carcinoma.组织多肽抗原（TPA）作为人类前列腺癌的预后辅助指标。
Prostate. 1985;6(3):285-91. doi: 10.1002/pros.2990060308.
9
[Urinary excretion of cholesterol in various diseases. (Especially in cancer of the urogenital system)].[各种疾病中胆固醇的尿排泄情况。（尤其在泌尿生殖系统癌症中）]
Osterr Z Erforsch Bekampf Krebskr. 1971;26(1):25-35.
10
Urinary evaluation of tumor-associated antigens in urothelial bladder tumors.尿路上皮膀胱癌中肿瘤相关抗原的尿液评估
Prog Clin Biol Res. 1991;370:179-84.
引用本文的文献
1
A Systematic Review of the Diagnostic and Prognostic Value of Urinary Protein Biomarkers in Urothelial Bladder Cancer.尿蛋白生物标志物在上尿路上皮癌诊断和预后价值的系统评价
Bladder Cancer. 2016 Jul 27;2(3):301-317. doi: 10.3233/BLC-160054.
2
Urine-TPA (tissue polypeptide antigen), flow cytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma.尿组织多肽抗原（TPA）、流式细胞术及细胞学作为膀胱癌肿瘤侵袭性标志物的研究
Urol Res. 1989;17(5):269-72. doi: 10.1007/BF00262980.
本文引用的文献
1
Chemical studies of tissue polypeptide antigen (TPA). II. Partial amino acid sequences of cyanogen bromide fragments of TPA subunit B1.
Acta Chem Scand B. 1980;34(4):265-73. doi: 10.3891/acta.chem.scand.34b-0265.
2
The clinical significance of tissue polypeptide antigen (TPA) in the urine of bladder cancer patients.
Br J Urol. 1981 Dec;53(6):578-81. doi: 10.1111/j.1464-410x.1981.tb03264.x.
3
Frequent elevation of tissue polypeptide antigen in the sera of workers exposed to bladder carcinogens.
Int J Cancer. 1978 Nov 15;22(5):542-5. doi: 10.1002/ijc.2910220506.
Zotero 插件